Trinity College Dublin’s Professor honoured with Irish Society for Immunology Annual Award

Professor Lavelle, from Trinity’s School of Biochemistry and Immunology, has been recognised for his significant contribution to Irish immunology research and education.

Professor Lavelle’s research is primarily focused on developing injectable and mucosal vaccines for infectious diseases and on resolving their mode of action.

His research group, based in the Trinity Biomedical Sciences Institute (TBSI), is also focused on developing therapeutic vaccines for cancer and investigating vaccine strategies that promote immunogenic cell death leading to enhanced protective immunity.

Professor Lavelle, who was elected a member of the Royal Irish Academy (MRIA) in 2021 in recognition of his contributions to the vaccine field, is the current President of the European Congress of Immunology (ECI) 2024.

Professor Lavelle will present a public lecture at 7 pm this evening in the Tercentenary Hall in TBSI entitled Getting to the core of how vaccines work as part of his award ceremony. Everyone is welcome to attend.

He said: “This is a golden era for vaccine research and we hope that our work on vaccine adjuvants can contribute to further advances, particularly for cancer vaccination where there is a desperate need for novel and more effective approaches.”

Professor Lavelle will also deliver his inaugural lecture, Adjuvants – plotting a path towards protective immunity against infection and cancer, between 6 and 7:30 pm on Tuesday 23rd May in Trinity Business School.